Abbott | ABT - Zinsaufwendungen Für Schuld

Aktienkurs
91.13
Täglich Wechseln
-1.35 -1.46%
Monatlich
-13.07%
Jährlich
-29.27%
Q2 Prognose
89.18




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Agilent USD 25M 2M 2025-12
AtriCure USD 1.33M 17K 2025-09
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 22.4M 2M 2025-12
Danaher USD 63M 8M 2026-03
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 17K 5.1B 2025-12
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 20.11B 58.39B 2026-03
J&J USD 43M 25M 2026-03
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Pfizer USD 711M 59M 2025-12
Smith & Nephew USD 69M 1000K 2025-12
Solventum Corp USD 51M 13.92B 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Terumo JPY 463M 445M 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12